Document is current
Any future updates will be listed below
-
Authors
Simkó, Attila
Ruiter, Simone
Löfstedt, Tommy
Garpebring, Anders
Nyholm, Tufve
Bylund, Mikael
Jonsson, Joakim
-
Funding
Funding for this research was provided by:
Cancer Research Foundation in Northern Sweden (LP 18-2182)
Swedish Research Council, Sweden (2018-05973)
Swedish National Infrastructure for Computing, Sweden
Umea University
- License Information
-
More Information
Article History
Received: 9 May 2023
Accepted: 25 September 2023
First Online: 2 October 2023
Declarations
:
: The pelvic model was trained and validated on an in-house dataset. The scans were captured using a GE Signa 3T PET/MR (GE Healthcare, Chicago, Illinois, United States) at the University Hospital of Umeå, Sweden. All experimental protocols were approved by the Swedish Ethical Review Authority (ethical approval Dnr: 2019-02666), and all methods were carried out in accordance with relevant guidelines and regulations. All participants were adults and their informed consent was obtained.
: Not applicable.
: The qualitative evaluations were performed using Hero Imaging, NONPI Medical AB, where Attila Simkó is an employee and Tommy Löfstedt, Anders Garpebring, Tufve Nyholm, and Joakim Jonsson are co-owners. Simone Ruiter and Mikael Bylund declare that they have no competing interests.
